Home › NDC Lookup › RxCUI directory › RxCUI 477560

Fenofibrate 145 MG Oral Tablet — RxCUI 477560

RxNorm drug concept · Semantic clinical drug
RxCUI 477560 Semantic clinical drug · SCD ● Current RxNorm concept 61 FDA products 125 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI477560
Official nameFenofibrate 145 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped61
Package NDCs mapped125
Reported Medicaid activity (SDUD)572,386 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fenofibrate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It helps lower triglycerides, and in some products LDL cholesterol, while raising HDL in some cases. It works alongside a healthy diet, not instead of one. Which uses apply depends...
  • It depends on the product. Tricor tablets and some capsules like Antara can be taken with or without food, while Lipofen should be taken with food. Check your label or ask me, and...
  • Common ones include abdominal pain, back pain, headache, nausea, constipation and a stuffy nose. It can also raise liver enzymes, which is why you will need blood tests.
  • Call right away for muscle pain or weakness, dark urine, yellow skin or eyes, severe belly pain, or leg swelling and chest pain. Seek emergency help for facial swelling, trouble br...
📖 Read our full Fenofibrate guide →

🕸️ Concept Web — How Fenofibrate 145 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fenofibrate 145 MG Oral Tablet RxCUI 477560

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fenofibrate 8703
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tricor 220456
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fenofibrate Oral Tablet 379818
    • Fenofibrate Oral Product 1159042
    • Fenofibrate Pill 1159043
    • Fenofibrate Oral Tablet [Tricor] 368613
    • Tricor Oral Product 1182714
    • Tricor Pill 1182715
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fenofibrate 145 MG SCDC · 477561
  • Fenofibrate Oral Tablet SCDF · 379818
  • Fenofibrate Oral Product SCDG · 1159042
  • Fenofibrate Pill SCDG · 1159043

Brand-Name Concepts

  • Fenofibrate 145 MG Oral Tablet [Tricor] SBD · 540281
  • Fenofibrate 145 MG [Tricor] SBDC · 540280
  • Fenofibrate Oral Tablet [Tricor] SBDF · 368613
  • Tricor Oral Product SBDG · 1182714
  • Tricor Pill SBDG · 1182715
  • Tricor BN · 220456

📦 FDA Products & Package NDCs

61 products · 125 package NDCs
125 package NDCs map to RxCUI 477560 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00378-3065-77 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3065-77) Fenofibrate Mylan Pharmaceuticals Inc. 2013-05-14
00378-3066-05 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3066-05) Fenofibrate Mylan Pharmaceuticals Inc. 2013-05-14
00378-3066-77 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3066-77) Fenofibrate Mylan Pharmaceuticals Inc. 2013-05-14
00615-8530-39 30 TABLET in 1 BLISTER PACK (0615-8530-39) FENOFIBRATE NCS HealthCare of KY, LLC dba Vangard Labs 2024-09-18
00904-7161-61 100 BLISTER PACK in 1 CARTON (0904-7161-61) / 1 TABLET in 1... FENOFIBRATE Major Pharmaceuticals 2016-12-15
00904-7480-04 30 BLISTER PACK in 1 CARTON (0904-7480-04) / 1 TABLET in 1... Fenofibrate Major Pharmaceuticals 2025-02-19
00904-7480-61 100 BLISTER PACK in 1 CARTON (0904-7480-61) / 1 TABLET in 1... Fenofibrate Major Pharmaceuticals 2025-02-19
31722-0595-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-595-30) Fenofibrate Camber Pharmaceuticals, Inc. 2016-07-14
31722-0595-31 100 TABLET, FILM COATED in 1 BLISTER PACK (31722-595-31) Fenofibrate Camber Pharmaceuticals, Inc. 2016-07-14
31722-0595-32 100 TABLET, FILM COATED in 1 BLISTER PACK (31722-595-32) Fenofibrate Camber Pharmaceuticals, Inc. 2016-07-14
31722-0595-90 90 TABLET, FILM COATED in 1 BOTTLE (31722-595-90) Fenofibrate Camber Pharmaceuticals, Inc. 2016-07-14
31722-0596-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-596-30) Fenofibrate Camber Pharmaceuticals, Inc. 2016-07-14
31722-0596-31 70 TABLET, FILM COATED in 1 BLISTER PACK (31722-596-31) Fenofibrate Camber Pharmaceuticals, Inc. 2016-07-14
31722-0596-32 100 TABLET, FILM COATED in 1 BLISTER PACK (31722-596-32) Fenofibrate Camber Pharmaceuticals, Inc. 2016-07-14
31722-0596-90 90 TABLET, FILM COATED in 1 BOTTLE (31722-596-90) Fenofibrate Camber Pharmaceuticals, Inc. 2016-07-14
33342-0339-07 30 TABLET in 1 BOTTLE (33342-339-07) Fenofibrate Macleods Pharmaceuticals Limited 2024-11-13
33342-0339-10 90 TABLET in 1 BOTTLE (33342-339-10) Fenofibrate Macleods Pharmaceuticals Limited 2024-11-13
33342-0339-12 10 BLISTER PACK in 1 CARTON (33342-339-12) / 10 TABLET in 1... Fenofibrate Macleods Pharmaceuticals Limited 2024-11-13
33342-0339-15 500 TABLET in 1 BOTTLE (33342-339-15) Fenofibrate Macleods Pharmaceuticals Limited 2024-11-13
33342-0340-07 30 TABLET in 1 BOTTLE (33342-340-07) Fenofibrate Macleods Pharmaceuticals Limited 2024-11-13
33342-0340-10 90 TABLET in 1 BOTTLE (33342-340-10) Fenofibrate Macleods Pharmaceuticals Limited 2024-11-13
33342-0340-12 10 BLISTER PACK in 1 CARTON (33342-340-12) / 10 TABLET in 1... Fenofibrate Macleods Pharmaceuticals Limited 2024-11-13
33342-0340-15 500 TABLET in 1 BOTTLE (33342-340-15) Fenofibrate Macleods Pharmaceuticals Limited 2024-11-13
35561-0249-03 500 TABLET, FILM COATED in 1 BOTTLE (35561-249-03) Fenofibrate Bostal LLC 2025-08-07
35561-0249-10 30 TABLET, FILM COATED in 1 BOTTLE (35561-249-10) Fenofibrate Bostal LLC 2021-01-01
35561-0249-11 90 TABLET, FILM COATED in 1 BOTTLE (35561-249-11) Fenofibrate Bostal LLC 2025-08-15
35561-0249-13 500 TABLET, FILM COATED in 1 BOTTLE (35561-249-13) Fenofibrate Bostal LLC 2021-01-01
35561-0250-03 500 TABLET, FILM COATED in 1 BOTTLE (35561-250-03) Fenofibrate Bostal LLC 2025-08-07
35561-0250-10 30 TABLET, FILM COATED in 1 BOTTLE (35561-250-10) Fenofibrate Bostal LLC 2021-01-01
35561-0250-11 90 TABLET, FILM COATED in 1 BOTTLE (35561-250-11) Fenofibrate Bostal LLC 2025-08-15
35561-0250-13 500 TABLET, FILM COATED in 1 BOTTLE (35561-250-13) Fenofibrate Bostal LLC 2021-01-01
42291-0045-90 90 TABLET, FILM COATED in 1 BOTTLE (42291-045-90) Fenofibrate AvKARE 2024-01-04
42385-0950-11 1000 TABLET in 1 BOTTLE (42385-950-11) fenofibrate Laurus Labs Limited 2020-03-18
42385-0950-30 30 TABLET in 1 BOTTLE (42385-950-30) fenofibrate Laurus Labs Limited 2020-03-18
42385-0950-90 90 TABLET in 1 BOTTLE (42385-950-90) fenofibrate Laurus Labs Limited 2020-03-18
42385-0951-11 1000 TABLET in 1 BOTTLE (42385-951-11) fenofibrate Laurus Labs Limited 2020-03-18
42385-0951-30 30 TABLET in 1 BOTTLE (42385-951-30) fenofibrate Laurus Labs Limited 2020-03-18
42385-0951-90 90 TABLET in 1 BOTTLE (42385-951-90) fenofibrate Laurus Labs Limited 2020-03-18
43353-0272-30 30 TABLET in 1 BOTTLE (43353-272-30) Tricor Aphena Pharma Solutions - Tennessee, LLC 2017-01-27
43353-0272-83 3600 TABLET in 1 BOTTLE (43353-272-83) Tricor Aphena Pharma Solutions - Tennessee, LLC 2017-01-27
43547-0430-09 90 TABLET in 1 BOTTLE (43547-430-09) FENOFIBRATE Solco Healthcare US, LLC 2019-02-20
43547-0430-50 500 TABLET in 1 BOTTLE (43547-430-50) FENOFIBRATE Solco Healthcare US, LLC 2019-02-20
43547-0431-09 90 TABLET in 1 BOTTLE (43547-431-09) FENOFIBRATE Solco Healthcare US, LLC 2019-02-20
43547-0431-50 500 TABLET in 1 BOTTLE (43547-431-50) FENOFIBRATE Solco Healthcare US, LLC 2019-02-20
46708-0360-30 30 TABLET, FILM COATED in 1 BOTTLE (46708-360-30) FENOFIBRATE Alembic Pharmaceuticals Limited 2019-08-09
46708-0360-71 500 TABLET, FILM COATED in 1 BOTTLE (46708-360-71) FENOFIBRATE Alembic Pharmaceuticals Limited 2019-08-09
46708-0360-90 90 TABLET, FILM COATED in 1 BOTTLE (46708-360-90) FENOFIBRATE Alembic Pharmaceuticals Limited 2019-08-09
46708-0361-30 30 TABLET, FILM COATED in 1 BOTTLE (46708-361-30) FENOFIBRATE Alembic Pharmaceuticals Limited 2019-08-09
46708-0361-71 500 TABLET, FILM COATED in 1 BOTTLE (46708-361-71) FENOFIBRATE Alembic Pharmaceuticals Limited 2019-08-09
46708-0361-90 90 TABLET, FILM COATED in 1 BOTTLE (46708-361-90) FENOFIBRATE Alembic Pharmaceuticals Limited 2019-08-09
Observed labelers: Bryant Ranch Prepack (12) · Aurobindo Pharma Limited (10) · Bostal LLC (8) · Camber Pharmaceuticals, Inc. (8) · Macleods Pharmaceuticals Limited (8) · A-S Medication Solutions (6) · +24 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.